跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Product-118
首页
药物
Product-118
Product-118
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD OF FILLING AT LEAST ONE DEGASSED DRUG PRODUCT INTO CONTAINERS AND DRUG PRODUCT FILLING DEVICE
WO 2020021073 A1
申请人: HOFFMANN LA ROCHE
优先权: 2018
CN
WO
2 件公开
Balsam-coffee-juice and manufacture method thereof
CN 101204185 A
申请人: FUSHUN KANGMAIXIN BIOLOG PRODU
优先权: 2006
CN
Foods for preventing atherosis and production method thereof
CN 101194722 A
申请人: BEIJING ZHONGKE YONGHE MEDICAL
优先权: 2007
CN
Method for removing ethylene glycol monomethyl ether impurity in coarse product of morpholine device
CN 102002019 A
申请人: JILIN INST CHEMICAL TECHNOLOGY
优先权: 2010
CN
Synthesis of 1-N-(2,6-dimethyl phenyl)-2-piperidinecarboxamide
CN 102558030 A
申请人: SHANDONG FANGMING PHARMACEUTICAL CO LTD
优先权: 2010
CN
Method for preparing aloe injection by using aloe liquid
CN 103463378 A
申请人: KAIFENG JIUFULAI BIOLOG TECHNOLOGY CO LTD
优先权: 2013
CN
Uses of maltol in preparation of acute kidney injury prevention drugs
CN 104825439 A
申请人: UNIV JILIN AGRICULTURAL
优先权: 2015
CN
Preparation method of (R)-(+)-lipoic acid
CN 105524040 A
申请人: SUZHOU FUSHILAI PHARMACEUTICAL CO LTD
优先权: 2016
CN
Sugar-free liver benefiting and eyesight improving oral liquid and preparation method thereof
CN 106266561 A
申请人: GUANGXI HUIBAOYUAN PHARMACEUTICAL TECH CO LTD
优先权: 2016
CN
Method for reducing content of genotoxic impurities of indobufen
CN 114516827 A
申请人: HANGZHOU ZHONGMEI EAST CHINA PHARMACY LTD COMPANY
优先权: 2020
CN
第 1 / 2 页
上一页
下一页
药物
反馈